Disclaimers & Citations

Disclaimer

BeSound ultrasound technology is under development and is subject to ongoing testing. BeSound technology has not been authorized by any regulatory authority for commercial sale.

Citations (*)

01. 50% Of Women over 40 Have Dense Breasts. Dense Breasts are a risk factor for breast cancer.
https://densebreast-info.org
02. 40% Of Cancers in Women with Dense Breasts are missed by mammography.
DenseBreast.org
03. 28 days is the amount of time it can take from initial screening to Breast Cancer Diagnosis, and still longer before treatment begins.
https://www.ncbi.nlm.nih.gov/…articles/PMC5482732/
04. 311,000 is the number of Women who will be diagnosed with breast cancer this yearhttps://www.cancer.org/cancer…s-breast-cancer.html
With clinically proven technology proven to reduce false-positives and the need for breast biopsies.https://clinicaltrials.gov/study/NCT01943916

Ultrasound and photoacoustic imaging provided by Seno Medical

https://senomedical.com/

BeSound is coming soon!

Sign up for our newsletter & updates

!
Please indicate if you are a clinician or a patient.
!
Please enter a valid email address.
Your submission has been received. Thank you, and welcome to the BeSound family!
Oops! Something went wrong!

Clinical study information

Company updates

Better Breast Health newsletter